메뉴 건너뛰기
Acta Oncologica
Volumn 49, Issue 6, 2010, Pages 872-874
Radiological response in an incidental meningioma in a patient treated with chemotherapy combined with CP-751,871, an IGF-1R inhibitor
Author keywords

[No Author keywords available]
Indexed keywords

CISPLATIN; CP 751871; GEMCITABINE;
EID: 77954487491     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841861003752408     Document Type: Letter
Times cited : (9)
References (7)
  • 1
    • 0035843243 scopus 로고    scopus 로고
    • Brain tumors
    • DeAngelis LM. Brain tumors. N Engl J Med 2001;344:114-123
    • (2001) N Engl J Med , vol.344 , pp. 114-123
    • Deangelis, L.M.1
  • 2
    • 0031030863 scopus 로고    scopus 로고
    • The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B
    • Kaba SE, DeMonte F, Bruner JM, Kyritsis AP, Jaeckle KA, Levin V, et al. The treatment of recurrent unresectable and malignant meningiomas with interferon alpha-2B. Neurosurgery 1997;40:271-275
    • (1997) Neurosurgery , vol.40 , pp. 271-275
    • Kaba, S.E.1    Demonte, F.2    Bruner, J.M.3    Kyritsis, A.P.4    Jaeckle, K.A.5    Levin, V.6
  • 3
    • 55749100671 scopus 로고    scopus 로고
    • Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas
    • Marc C. Chamberlain MJG. Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas. Cancer 2008;113:2146-2151
    • (2008) Cancer , vol.113 , pp. 2146-2151
    • Marc, C.1    Mjg, C.2
  • 4
    • 20144386856 scopus 로고    scopus 로고
    • Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751, 871
    • Cohen BD, Baker DA, Soderstrom C, Tkalcevic G, Rossi AM, Miller PE, et al. Combination therapy enhances the inhibition of tumor growth with the fully human anti-type 1 insulin-like growth factor receptor monoclonal antibody CP-751,871. Clin Cancer Res 2005;11:2063-2073
    • (2005) Clin Cancer Res , vol.11 , pp. 2063-2073
    • Cohen, B.D.1    Baker, D.A.2    Soderstrom, C.3    Tkalcevic, G.4    Rossi, A.M.5    Miller, P.E.6
  • 5
    • 54949138880 scopus 로고    scopus 로고
    • Synergic antitumoral effect of an IGF-IR inhibitor and trastuzumab on HER2-overexpressing breast cancer cells
    • Esparis-Ogando A, Ocana A, Rodriguez-Barrueco R, Ferreira L, Borges J, Pandiella A. Synergic antitumoral effect of an IGF-IR inhibitor and trastuzumab on HER2-overexpressing breast cancer cells. Ann Oncol 2008;19:1860-1869
    • (2008) Ann Oncol , vol.19 , pp. 1860-1869
    • Esparis-Ogando, A.1    Ocana, A.2    Rodriguez-Barrueco, R.3    Ferreira, L.4    Borges, J.5    Pandiella, A.6
  • 6
    • 0036280560 scopus 로고    scopus 로고
    • Expression of i GF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness
    • Sandberg Nordqvist A-C, Mathiesen T. Expression of I GF-II, IGFBP-2, -5, and -6 in meningiomas with different brain invasiveness. J Neurooncol 2002;57:19-26.
    • (2002) J Neurooncol , vol.57 , pp. 19-26
    • Sandberg Nordqvist, A.-C.1    Mathiesen, T.2
  • 7
    • 66349091290 scopus 로고    scopus 로고
    • Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer
    • Karp DD, Paz-Ares LG, Novello S, Haluska P, Garland L, Cardenal F, et al. Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer. J Clin Oncol 2009;27:2516-2522
    • (2009) J Clin Oncol , vol.27 , pp. 2516-2522
    • Karp, D.D.1    Paz-Ares, L.G.2    Novello, S.3    Haluska, P.4    Garland, L.5    Cardenal, F.6

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.